Valo Therapeutics
Valo Therapeutics is an immunooncology company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines.
Total raised
€33M
€33,330,000
Funding rounds
4
Investors
7
distinct backers
Active since
2020-02
latest 2025-03
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood37
base rate 30% for Other
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood22
base rate 12% (2+ rounds)
- ▲ 4 rounds raised
- ▲ €30M+ raised
- ▲ 10y since founding
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-03-10 | Other | €19M | CDP Venture Capital Sgr,ENEA Tech e Biomedical,Freeman Road,Indaco Venture Partners SGR | View deal → |
| 2023-02-15 | Other | €2.2M | European Innovation Council | View deal → |
| 2021-11-15 | Pre-Seed | €11M | Freeman Road,MMJ Group Holdings | View deal → |
| 2020-02-06 | Other | €1.1M | Business Finland | View deal → |
Investors
7Related news
- Valo Therapeutics Raises EUR 2.23M from the European Innovation Councilfinsmes.com · 2023-02
- Valo Therapeutics Raises €11M in Fundingfinsmes.com · 2021-11
- siliconcanals.com
- valotx.com
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Iceye€1.5BFinland · Space
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Nokia€859MFinland · Telecom